| Product Name | MF | CAS | Details |
|---|
| Etoricoxib Solution, 100ppm;Etoricoxib (MK-663;Etoricoxib Tablets;Etoricoxib(5-chloro-6'-Methyl-3-(4-(Methylsulfonyl)phenyl)-2,3'-bipyridine; | C18H15ClN2O2S | 202409-33-4 | Details |
| AZD2281(olaparib);4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one | C24H23FN4O3 | 763113-22-0 | Details |
| Nintedanib esylate | C33H39N5O7S | 656247-18-6 | Details |
| KX2-391 | C26H29N3O3 | 897016-82-9 | Details |
| 2,6-Dichlorophenolindophenol sodium salt xhydrate | C12H10Cl2NNaO3 | 1266615-56-8 | Details |
| AZD-9291 | C28H33N7O2 | 1421373-65-0 | Details |
| Brensocatib | C23 H24 N4 O4 | 1802148-05-5 | Details |
| Nemorexant;Methanone, [(2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl][5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]-;Daridorexant | C23H23ClN6O2 | 1505484-82-1 | Details |
| CP-690550(Tasocitinib,CP690550);CP 690550(Tasocitinib);Tasocitinib;3-((3R,4R)-4-Methyl-3-(Me...;Tasocitinib (CP 690550) | C16H20N6O | 477600-75-2 | Details |
| Gepirone | C19H29N5O2 | 83928-76-1 | Details |
| Tetrabromophenol blue | C19H6Br8O5S | 4430-25-5 | Details |
| Morpholine hydrochloride | C4H10ClNO | 10024-89-2 | Details |
| TG101348; TG 101348; TG-101348; SAR302503; SAR-302503; SAR 302503; FEDRATINIB.;TG101348(Fedratinib);CS-57;TG-101348; TG 101348; | C27H36N6O3S | 936091-26-8 | Details |
| ApreMilast,CC-10004;brand name: Otezla.;CC10004; CC-10004; CC 10004; APREMILAST; BRAND NAME: OTEZLA.; | C22H24N2O7S | 608141-41-9 | Details |
| KPT-330;(2Z)-3-[3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid 2-(2-pyrazinyl)hydrazide;Selinexor; | C17H11F6N7O | 1393477-72-9 | Details |
| aprocitentan | C16H14Br2N6O4S | 1103522-45-7 | Details |
| sparsentan | C32H40N4O5S | 254740-64-2 | Details |
| DFSX-2;Ethyl1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate; | C24H23F3N4O5 | 442526-91-2 | Details |
| Linezolid-13C-d3;Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- (9CI); | C16H20FN3O4 | 165800-03-3 | Details |
| POLY(VINYL METHYL ETHER) | C9H18O3X2 | 9003-09-3 | Details |
| Triisopropanolamine Borate | C9H18BNO3 | 101-00-8 | Details |
| aficamten | C18H19N5O2 | 2364554-48-1 | Details |
| Undecylenoyl phenylalanine | C20H29NO3 | 175357-18-3 | Details |
| AZILSARTAN;2-Ethoxy-1-[[2'-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid Azilsartan; | C25H20N4O5 | 147403-03-0 | Details |
| Prucalopride | C18H26ClN3O3 | 179474-81-8 | Details |
| N(4)-hydroxycytidine | C9H13N3O6 | 3258-02-4 | Details |
| 2,5,6-TRICHLORO-1H-BENZIMIDAZOLE | C7H3Cl3N2 | 16865-11-5 | Details |
| Mirabegron;N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide;YM 178;Mirabegron(YM 178) | C21H24N4O2S | 223673-61-8 | Details |
| Momelotinib | C23H22N6O2 | 1056634-68-4 | Details |
| Dacomitinib | C24H25ClFN5O2 | 1110813-31-4 | Details |
| 6-CHLORO-3-(1-METHYLETHYL)-2,4-(1H,3H)-PYRIMIDINEDIONE | C7H9ClN2O2 | 887581-47-7 | Details |
| Trelagliptin succinate | C22H26FN5O6 | 1029877-94-8 | Details |
| Vonoprazan;1-[5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrol-3-yl]-N-methylmethanamine; | C17H16FN3O2S | 881681-00-1 | Details |
| Fruquintinib | C21H19N3O5 | 1194506-26-7 | Details |
| Asciminib | C20H18ClF2N5O3 | 1492952-76-7 | Details |
| Mavacamten | C15H19N3O2 | 1642288-47-8 | Details |
| 2,4-Dichlorobenzenediazonium tetrafluoroborate | C6H3BCl2F4N2 | 21872-70-8 | Details |
| Tolvaptan Sodium Phosphate | C26H27ClN2NaO6P | 942619-79-6 | Details |
| N-(2-Acetamido)iminodiacetic acid | C6H10N2O5 | 26239-55-4 | Details |
| NS-304;Selexipag;ACT-293987;NS-304(Selexipag);Selexipag API | C26H32N4O4S | 475086-01-2 | Details |
| VX-770 | C24H28N2O3 | 873054-44-5 | Details |
| Trametinib free base;Mekinist trametinib;Trametinib (GSK1120212,JTP 74057);Trametinib, >=98%;CS-30;Trametinib Impurity;100836 | C26H23FIN5O4 | 871700-17-3 | Details |
| LEE011, >=98%;7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE;LEE-011, Ribociclib; | C23H30N8O | 1211441-98-3 | Details |
| n-methyl-3-(2-methylphenoxy)benzenepropanamine;(r)-tomoxetine;Tomoxetine;TomoxetineHcl; | C17H21NO | 83015-26-3 | Details |
| Acoramidis | C15H17FN2O3 | 1446711-81-4 | Details |
| Pirtobrutinib | C22H21F4N5O3 | 2101700-15-4 | Details |
| PF07321332(Paxlovid);nirmatrelvir;Nirmatrelvir (PF-07321332);PF-07321332-005; | C23H32F3N5O4 | 2628280-40-8 | Details |
| N-Desmethyl lmatinib | C28H29N7O | 404844-02-6 | Details |
| PA-824 | C14H12F3N3O5 | 187235-37-6 | Details |
| Xanomeline | C14H23N3OS | 131986-45-3 | Details |
| Tolvaptan | C26H25ClN2O3 | 150683-30-0 | Details |
| Resmetirom (MGL-3196,VIA-3196);MGL-3196; MGL 3196; MGL3196; VIA-3196; VIA3196; VIA-3196;VIA3196;VIA-3196; | C17H12Cl2N6O4 | 920509-32-6 | Details |
| Resmetirom (MGL-3196,VIA-3196);MGL-3196; MGL 3196; MGL3196; VIA-3196; VIA3196; VIA-3196;VIA3196;VIA-3196; | C17H12Cl2N6O4 | 920509-32-6 | Details |
| 0DM021;BAY-1841788;ODM-021;0DM021;ODM 021;ODM 021;ODM-021;ODM-201 | C19H19ClN6O2 | 1297538-32-9 | Details |
| 2-Methoxy-4-morpholinobenzenediazonium chloride zinc chloride double salt | C11H14Cl4N3O2Zn- | 67801-08-5 | Details |
| 4'-AMINOPROPIOPHENONE | C9H11NO | 70-69-9 | Details |
| Dotinurad | C14H9Cl2NO4S | 1285572-51-1 | Details |
| REMIBRUTINIB | C27H27F2N5O3 | 1787294-07-8 | Details |
| Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
| 3-Guanidinopropionic acid | C4H9N3O2 | 353-09-3 | Details |
| Zongertinib | C29H29N9O2 | 2728667-27-2 | Details |
| Ticagrelor, >=98%;Ticagrelo;Ticargrelor;Brilinta;Possia;Ticagrelor and intermediates;Ticagrelor Standards | C23H28F2N6O4S | 274693-27-5 | Details |
| afamidis (Fx1006A);Tafamidis free acid;PF-06291826(Tafamidis);TafaMidis;Fx 1006; | C14H7Cl2NO3 | 594839-88-0 | Details |
| Empagliflozin(W.S);Empaglifloin;Empagliflozin API;BI-10773;BI 10773;BI10773;CS-798;EMPAGLIFLBZIN;EMpagliflozin;BI-10773 | C23H27ClO7 | 864070-44-0 | Details |
| Brexpiprazole | C25H27N3O2S | 913611-97-9 | Details |
| Brexpiprazole | C25H27N3O2S | 913611-97-9 | Details |
| nerandomilast | C20H26ClN6O2S- | 1423719-30-5 | Details |
| Alogliptin benzoate | C25H27N5O4 | 850649-62-6 | Details |
| Tri(4-morpholinyl)phosphine oxide | C12H24N3O4P | 4441-12-7 | Details |
| Dabigatran etexilate | C34H41N7O5 | 211915-06-9 | Details |
| AF-802;CH-5424802/RG-7853;Alectinib (CH5424802);AF 802; AF-802; AF802; CH5424802; CH5424802; CH 5424802; RO5424802; RO 5424802; RO5424802, ALECTINIB; | C30H34N4O2 | 1256580-46-7 | Details |
| AHU-377,149709-62-6;AHU-37;AHU377; AHU 377; SACUBITRIL | C24H29NO5 | 149709-62-6 | Details |
| IMegliMin(hydrochloride) | C6H14ClN5 | 775351-61-6 | Details |
| Salcaprozate Sodium | C15H22NNaO4 | 203787-91-1 | Details |
| Daprodustat | C19H27N3O6 | 960539-70-2 | Details |
| Revefenacin | C35H43N5O4 | 864750-70-9 | Details |
| BENZIMIDAVIR | C15H19Cl2N3O4 | 176161-24-3 | Details |
| 1-(4-Nitrophenyl)acetone;2-Propanone,1-(4-nitrophenyl)-; | C9H9NO3 | 5332-96-7 | Details |
| Risdiplam | C22H23N7O | 1825352-65-5 | Details |
| Safinamide | C17H19FN2O2 | 133865-89-1 | Details |
| Methyl Green | C27H35BrCl3N3Zn | 7114-03-6 | Details |
| Cinacalcet Hydrochloride;N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride; | C22H23ClF3N | 364782-34-3 | Details |
| ISOPROPYLUREA | C4H10N2O | 691-60-1 | Details |
| 1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI);IMegliMin;EMD 387008;R-IMegliMin;EMD 387008/R-Imeglimin;EMD 387008 (R-IMEGLIMIN) HCL; | C6H13N5 | 775351-65-0 | Details |
| linagliptin;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; | C25H28N8O2 | 668270-12-0 | Details |
| Menaquinone 7 | C46H64O2 | 2124-57-4 | Details |
| INTEDANIB BASE;Nintedanib;Nintedanib (BIBF 1120);Nintedanib/Intedanib/Vargatef;BIBF 1120; VARGATEF; INTEDANIB;INTEDANIB BASE;Intedanib Vargatef;Nintedanib-016;100837 | C31H33N5O4 | 656247-17-5 | Details |
| 5',5''-Dinitro-3',3''-diiodo-3,4,5,6-trtrabromophenol-sulfonephthalein | C19H6Br4I2N2O9S | 145551-16-2 | Details |
| Avatrombopag | C29H34Cl2N6O3S2 | 570406-98-3 | Details |
| Carbozantinib;Cabozantinib(XL184Malate);Cabozantinib (XL184, BMS-907351); | C28H24FN3O5 | 849217-68-1 | Details |
| Abemaciclib, >=98%;Abemaciclib;abemaciclib(CDK 4/6 inhibitor);Abemaciclib (LY2835219);Bemaciclib(LY2835219, abemaciclib);CDK4/6 dual inhibitor; | C27H32F2N8 | 1231929-97-7 | Details |
| 7-Chloro-[1,2,4]triazolo[1,5-a]pyridine | C6H4ClN3 | 1427452-48-9 | Details |
| Mitapivat | C24H26N4O3S | 1260075-17-9 | Details |
| Finerenone (BAY 94-8862);(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide;BAY 94-8862;BAY948862; | C21H22N4O3 | 1050477-31-0 | Details |
| ETC-1002;Bempedoic Acid;ETC-1002 (ESP 55016);ESP 55016;ETC-1002(BEMPEDOIC ACID);CS-1544;Bempedoic Acid(ETC-1002;Bempedoate | C19H36O5 | 738606-46-7 | Details |
| Trilaciclib | C24H30N8O | 1374743-00-6 | Details |
| ROFLUMILAST;3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;B 9302-107;BY 217;BYK 20869;Daxas; | C17H14Cl2F2N2O3 | 162401-32-3 | Details |
| Trilaciclib | Details |
| TAK-788 | C32H39N7O4 | 1847461-43-1 | Details |
| Vazegepant | C36H46N8O3 | 1337918-83-8 | Details |
| ensifentrine | C26H31N5O4 | 1884461-72-6 | Details |
| Bilastine | C28H37N3O3 | 202189-78-4 | Details |
| 1,2,3,4-tetrahydro-benzo[h]quinolin-3-ol hydrochloride | C13H13NO.ClH | 73579-26-7 | Details |
| Rilpivirine | C22H18N6 | 500287-72-9 | Details |
| ACT 064992;ACT-064992;ACT-064992 / ACT064992;Macitentan, >=99%; | C19H20Br2N6O4S | 441798-33-0 | Details |
| 4-Aminopiperidine-4-carboxylic acid | C6H12N2O2 | 40951-39-1 | Details |
| Aripiprazole | C23H27Cl2N3O2 | 129722-12-9 | Details |
| Aripiprazole | C23H27Cl2N3O2 | 129722-12-9 | Details |
| AV951 (KRN951, Tivozanib) (stopped use since the patent issue);AV-951; KRN951; AV 951;AV951;CS-8; | C22H19ClN4O5 | 475108-18-0 | Details |
| Niraparib | C19H20N4O | 1038915-60-4 | Details |
| Opicapone | C15H10Cl2N4O6 | 923287-50-7 | Details |
| vericiguat | C19H16F2N8O2 | 1350653-20-1 | Details |
| Ethyl Isocyanatoacetate | C5H7NO3 | 2949-22-6 | Details |
| Exatecan;DX 8951;CS-147;Exatecan Impurity; | C24H22FN3O4 | 171335-80-1 | Details |
| ALOGLIPTIN(ALOG LIPTINE, ALOGLIPTINA) | C18H21N5O2 | 850649-61-5 | Details |
| (1-aMinocyclobutyl)Methanol | C5H11NO | 180205-34-9 | Details |
| ABT 492 MegluMine;ABT492 MegluMine;ABT-492 MegluMine;Delafloxacin (MegluMine) | C25H29ClF3N5O9 | 352458-37-8 | Details |
| Lifitegrast-d4;Lifitegrast Impurity;lifitegrast;Lifitegrast, SAR 1118 | C29H24Cl2N2O7S | 1025967-78-5 | Details |
| Solriamfetol;(S)-2-amino-3-phenylpropyl carbamate hydrochloride | 561069-23-6 | Details |
| 3-(N-tosyl-L-alanyloxy)-indole | C18H18N2O4S | 75062-54-3 | Details |
| Zanzalintinib | C29H25FN4O5 | 2367004-54-2 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||